GHK-Cu's Cu(II)-carrier mechanism does not engage the VEGFR2 receptor through which BPC-157 acts
Anthony RM, MacLeay JM, Jewell DE, Brejda JJ, Gross KL
The association appears indirect, mediated primarily through the metabolic and nutritional consequences of significant weight loss rather than through receptor-mediated effects on hair growth cycles
In addition, glucagon receptor stimulation increases energy expenditure, enhances fat oxidation, and improves lipid metabolism, contributing significantly to adipose tissue reduction (Elkasrawy & Hamrick, 2024)
Tirzepatide was FDA-approved to treat type 2 diabetes under the brand name Mounjaro in May 2002, and then it was also granted approval to be used for the treatment of obesity and weight management under the brand name Zepbound in November 2023